Alfred Welle

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: India

Consulting Services

Scientific Writing Pharma-CRO-Device Legal Support Sales and Marketing

Areas Of Interest

Interferon-Induced Helicase, IFIH1 Ultrasonography, Pulsed Doppler Wastewater-Based Epidemiological Monitorings Y Box Protein 1 Drug Design, Computerized Receptor, 5-HT4 Dianhydrosorbitol Spiny Lobsters Snail Family Transcription Factors Vagotomy, Highly Selective Receptor, Angiotensin AT2 Enzyme Inhibitors King Cobra Venom Megakaryocyte Erythroid Progenitor Cells RPR 102289A Electronic Transistors Leadership Psychosocial Support Systems Choline Acetyltransferase Transhydrogenase, Energy-Linked Amyloid Plaque Protection, Neuronal Lasers, Pulsed Dye Lesions, Bullous Immunoglobulin Secreting Cells Vomica, Nux Farnesyl Diphosphate Geranylgeranyl Diphosphate Synthase BL S578 Insulinoma Amyloid Polypeptide Precursor Beriberi

Professional Narrative

Dr. Alfred Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Mayo Clinic 2002
Medical Writer, Harvard Med 1989

Education

Doctor of medicine, Weill Medical College 2012
Doctor of osteopathic medicine, Baylor College 2000

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :